載入...
Inhibition of IKKβ/NF-κB signaling pathway to improve Dasatinib efficacy in suppression of cisplatin-resistant head and neck squamous cell carcinoma
Proto-oncogene tyrosine-protein kinase Src plays an important role in Head and Neck Squamous Cell Carcinoma (HNSCC). However, the FDA-approved SRC inhibitor Dasatinib shows very limited efficacy in HNSCC clinical trials, even though Dasatinib can completely inhibit SRC in the laboratory setting. The...
Na minha lista:
| 發表在: | Cell Death Discov |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Nature Publishing Group UK
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7229171/ https://ncbi.nlm.nih.gov/pubmed/32435511 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41420-020-0270-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|